[Webinar] Putting Artificial Intelligence in R&D   

October 26, 2020

Big Pharma and biotech are increasingly using artificial intelligence in drug discovery. Join a distinguished panel of experts on October 27th from 2:00pm – 3:00pm EDT as they use examples from their work to demonstrate how AI can speed the development of more drugs with better odds of success.



  • John D. Carroll, Founder and Editor of Endpoints News


  • Dr. David Schenkein, General Partner at GV
  • Anne Heatherington, Ph.D., Head of Takeda’s Data Science Institute
  • John Connolly, PhD, Chief Scientific Officer, Parker Institute for Cancer Immunotherapy
  • Maria Wendt, Head of Biologics Research, Sanofi
  • Karen Akinsanya, Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D, Schrödinger
  • Dr. Vern De Biasi, Vice President, Global Head of Strategic Partnerships, Cyclica

Register here.

Share This Story!